Swiss Life Asset Management Ltd Grows Stake in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-21T10:05:33+00:00

Swiss Life Asset Management increased its Regeneron Pharmaceuticals stake by 112% in Q3, owning 23,658 shares worth $13.3 million. Institutional investors hold 83.31% of the stock. Regeneron also reported strong Q4 earnings and raised its dividend.

NodeGuardian

2026-03-21 10:05:33

Abstract generation in progress

Swiss Life Asset Management Ltd significantly increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 112.0% in the third quarter, owning 23,658 shares valued at $13.3 million. Other institutional investors also adjusted their positions, with hedge funds and institutional investors collectively owning 83.31% of the company’s stock. Regeneron Pharmaceuticals recently reported strong Q4 earnings, surpassing analyst estimates, and increased its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.